General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 221: In myocardial infarction, fibrosis is typically seen after how many days?

A. 2 days
B. 5 days (Correct Answer)
C. 1 week
D. 3 weeks

Explanation: **Explanation:** The correct answer is **5 days**. This question tests the chronological sequence of morphological changes in Myocardial Infarction (MI), a high-yield topic for NEET-PG. **1. Why 5 days is correct:** Following the initial inflammatory phase (neutrophilic infiltration), the healing process begins. By **days 3 to 7**, the necrotic tissue is removed by macrophages, and **granulation tissue** begins to appear at the periphery of the infarct [1]. Granulation tissue is characterized by neo-angiogenesis and the proliferation of fibroblasts. The synthesis of collagen (fibrosis) starts as early as day 5, marking the transition from acute inflammation to the repair phase [2]. **2. Why other options are incorrect:** * **2 days:** At this stage, the predominant feature is **coagulative necrosis** and a heavy infiltrate of **neutrophils** [1]. Fibrosis has not yet begun. * **1 week:** While granulation tissue is well-established by day 7-10, the *onset* of fibrosis occurs earlier (around day 5) [2]. * **3 weeks:** By this time, the granulation tissue is being replaced by a dense collagenous scar. Fibrosis is well-advanced, not just beginning. **High-Yield Clinical Pearls for NEET-PG:** * **0–4 hours:** No gross changes; Electron Microscopy shows mitochondrial swelling [1]. * **12–24 hours:** Grossly, **dark mottling**; Microscopically, **contraction band necrosis** [1]. * **3–7 days:** Maximum risk of **myocardial rupture** (ventricular wall, septum, or papillary muscle) because the tissue is softest (yellow-tan softening) due to macrophage activity [1]. * **2 months:** Completion of the scarred, white fibrous infarct. * **Staining:** **Triphenyltetrazolium chloride (TTC)** stain is used to identify MI in fresh specimens (infarct appears pale/unstained) [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, p. 552. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 117-119. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 552-554.

Question 222: The primary defect in Xeroderma pigmentosa is:

A. Formation of thymidine dimers (Correct Answer)
B. Poly ADP ribose polymerase is defective
C. Exonuclease is defective
D. Formation of adenine dimers

Explanation: **Explanation:** **Xeroderma Pigmentosum (XP)** is an autosomal recessive genetic disorder characterized by an extreme sensitivity to ultraviolet (UV) radiation. [1] **1. Why Option A is Correct:** The primary event in XP is the **formation of pyrimidine dimers (specifically thymidine dimers)** in DNA when skin is exposed to UV light [1]. In healthy individuals, these dimers are repaired via the **Nucleotide Excision Repair (NER)** pathway. In XP patients, there is a deficiency in the enzymes required for this pathway (most commonly **UV-specific endonucleases**). The inability to repair these dimers leads to accumulated mutations, resulting in skin cancers at a very young age [1]. **2. Why Incorrect Options are Wrong:** * **Option B:** Poly ADP ribose polymerase (PARP) is involved in Base Excision Repair (BER) and detecting single-strand breaks. It is not the primary defect in XP. * **Option C:** While a defect in the repair pathway exists, the *primary defect* or initiating event mentioned in the context of the question's pathology is the **formation of the dimers** themselves which the body fails to excise. (Note: If the question asked for the defective *enzyme*, endonuclease would be the answer). * **Option D:** UV radiation specifically causes the linkage of adjacent pyrimidines (Thymine/Cytosine), not purines like Adenine [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** Autosomal Recessive. * **Clinical Triad:** Photophobia, severe sunburn/erythema, and early-onset skin cancers (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma). * **Key Enzyme Deficit:** UV-specific endonuclease (NER pathway). * **Associated Condition:** Cockayne Syndrome also involves NER defects but presents with "Mickey Mouse" facies and dwarfism without increased cancer risk. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 322-323.

Question 223: What is the cause for caseous necrosis in Tuberculosis?

A. Hydrolytic enzymes
B. Mycolic acid
C. High lipid content (Correct Answer)
D. Hydrophobic changes by the bacterial wall

Explanation: **Explanation:** Caseous necrosis is a unique form of cell death characteristic of granulomatous inflammation, most commonly seen in **Tuberculosis (TB)** [2]. The term "caseous" (cheese-like) refers to the friable, yellow-white macroscopic appearance of the necrotic area [1], [2]. **Why "High lipid content" is correct:** The hallmark of caseous necrosis is the destruction of tissue architecture into an amorphous, granular debris [1]. This occurs because *Mycobacterium tuberculosis* contains a high concentration of **lipids and waxes** (specifically within its complex cell wall) [4]. When macrophages die while attempting to engulf the bacilli, these lipids are released into the necrotic center. The combination of dead host cells and the waxy, lipid-rich bacterial components prevents complete liquefaction, resulting in the characteristic "cheesy" consistency. **Analysis of Incorrect Options:** * **A. Hydrolytic enzymes:** These are the primary drivers of **Liquefactive necrosis** (e.g., in brain infarcts or abscesses). In TB, these enzymes are partially inhibited, preventing total liquefaction. * **B. Mycolic acid:** While mycolic acid is a major component of the cell wall and contributes to acid-fastness, the macroscopic "caseous" appearance is attributed to the **total lipid load** rather than just this specific acid. * **D. Hydrophobic changes:** While the cell wall is hydrophobic, this is a physical property that aids survival and staining (Acid-fastness) but is not the direct cause of the necrotic morphology. **High-Yield Clinical Pearls for NEET-PG:** * **Microscopic Appearance:** Caseous necrosis appears as a structureless, eosinophilic (pink), granular area surrounded by a granuloma (epithelioid histiocytes, Langhans giant cells, and lymphocytes) [3]. * **Dystrophic Calcification:** Caseous centers often undergo calcification (e.g., Ghon complex). * **Contrast:** Unlike coagulative necrosis, the underlying tissue architecture is **completely lost** in caseous necrosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 383-384. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 55. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 109. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 379-380.

Question 224: Epigenetics deals with genetic modifications that do not alter the sequence of DNA. Which of the following methods cannot detect epigenetic modifications?

A. ChIP-on-chip
B. Bisulphite sequencing
C. High-performance liquid chromatography (HPLC) (Correct Answer)
D. Methylation-specific PCR

Explanation: **Explanation:** **Epigenetics** refers to heritable changes in gene expression that occur without altering the primary DNA sequence. The most common mechanisms include DNA methylation (usually at CpG islands) and histone modifications (acetylation/methylation) [1]. **Why HPLC is the correct answer:** High-performance liquid chromatography (HPLC) is a technique used to separate, identify, and quantify components in a mixture based on chemical properties. While it can quantify the *total* amount of methylated cytosine in a genomic sample, it **cannot detect specific epigenetic modifications** at particular gene loci or map where these changes occur in the genome. Therefore, it is not considered a standard tool for functional epigenetic mapping. **Analysis of Incorrect Options:** * **Bisulphite Sequencing:** The "Gold Standard" for detecting DNA methylation. Bisulphite treatment converts unmethylated cytosine to uracil, while methylated cytosine remains unchanged, allowing for base-pair resolution mapping. * **Methylation-specific PCR (MSP):** A rapid method using primers specifically designed to distinguish between methylated and unmethylated DNA sequences after bisulphite treatment. * **ChIP-on-chip:** Combines Chromatin Immunoprecipitation (ChIP) with microarray technology. It is used to identify sites where specific proteins (like modified histones or transcription factors) bind to the DNA. **Clinical Pearls for NEET-PG:** * **DNA Methylation:** Usually leads to **gene silencing** (transcriptional repression) [1]. * **Histone Acetylation:** Usually leads to **gene activation** (opens chromatin) [2]. * **Genomic Imprinting:** A classic epigenetic phenomenon (e.g., Prader-Willi and Angelman syndromes) where only one allele is expressed depending on parental origin. * **Cancer:** Hypermethylation of tumor suppressor genes (like *RB* or *BRCA1*) is a common epigenetic driver of malignancy [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 230-231. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 15-17. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 327-328.

Question 225: Xerostomia and enlargement of salivary and lacrimal glands are seen in which condition?

A. Sicca syndrome
B. Sjogren syndrome
C. Mickulicz disease (Correct Answer)
D. None of the above

Explanation: ### Explanation The correct answer is **Mikulicz disease**. **1. Why Mikulicz Disease is Correct:** Mikulicz disease is characterized by the **symmetrical, painless enlargement** of the lacrimal and salivary glands (parotid and submandibular) accompanied by **xerostomia** (dry mouth) and decreased lacrimation. Pathologically, it involves a dense lymphocytic infiltration of these glands. In modern classification, Mikulicz disease is considered a manifestation of **IgG4-related disease (IgG4-RD)**. It is distinguished from other conditions by the prominent, gross enlargement of the glands rather than just functional loss. **2. Why Other Options are Incorrect:** * **Sjögren Syndrome (Option B):** While Sjögren syndrome also presents with xerostomia and dry eyes (keratoconjunctivitis sicca), it is a systemic autoimmune disorder characterized by the presence of specific antibodies (**Anti-Ro/SSA and Anti-La/SSB**) [1]. While gland enlargement *can* occur [3], the hallmark is the functional dryness and systemic involvement [2]. * **Sicca Syndrome (Option A):** This term specifically refers to the combination of dry eyes and dry mouth *without* the presence of another connective tissue disease (Primary Sjögren’s) [3]. It focuses on the symptoms of dryness rather than the physical enlargement of the glands. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mikulicz Syndrome vs. Disease:** Mikulicz *Syndrome* is a clinical presentation where gland enlargement occurs secondary to other diseases like Sarcoidosis, Leukemia, or Lymphoma. Mikulicz *Disease* is the primary idiopathic form (IgG4-RD). * **Histology:** Look for "Epimyoepithelial islands" in salivary gland biopsies (common in Sjögren’s and Mikulicz). * **IgG4-RD Triad:** Storiform fibrosis, obliterative phlebitis, and dense lymphoplasmacytic infiltrate rich in IgG4+ plasma cells. * **Risk:** Patients with these conditions have a significantly increased risk (up to 40x) of developing **B-cell Non-Hodgkin Lymphoma** (specifically MALT lymphoma) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 235-236. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 236. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 749-750.

Question 226: Senile cardiac amyloidosis is associated with which protein?

A. Transthyretin (Correct Answer)
B. Atrial Natriuretic Peptide (ANP)
C. Beta 2 microglobulin
D. Gelsolin

Explanation: **Explanation:** Amyloidosis refers to the extracellular deposition of misfolded proteins that form insoluble fibrils. **Senile Systemic Amyloidosis (SSA)**, now more commonly referred to as Wild-Type Transthyretin Amyloidosis (ATTRwt), primarily affects the hearts of elderly patients (typically >70 years) [1]. **1. Why Transthyretin (TTR) is correct:** Transthyretin is a serum protein synthesized in the liver that transports thyroxine and retinol [1]. In the elderly, the **wild-type (non-mutated)** TTR protein can become unstable, misfold, and deposit as amyloid fibrils in the myocardium [3]. This leads to restrictive cardiomyopathy. Note that mutated TTR is associated with *Familial Amyloid Polyneuropathies* [1]. **2. Analysis of Incorrect Options:** * **Atrial Natriuretic Peptide (ANP):** Associated with **Isolated Atrial Amyloidosis**. Unlike senile systemic amyloidosis which affects the ventricles, ANP deposits are confined to the cardiac atria. * **Beta 2 microglobulin:** Associated with **Hemodialysis-associated amyloidosis** [1]. It typically presents as Carpal Tunnel Syndrome or joint involvement because the protein is not effectively filtered by dialysis membranes. * **Gelsolin:** Associated with **Familial Amyloidosis (Finnish type)**, a rare autosomal dominant systemic amyloidosis characterized by corneal lattice dystrophy and cranial neuropathy. **High-Yield NEET-PG Pearls:** * **Staining:** All amyloid types show **Apple-green birefringence** under polarized light when stained with **Congo Red** [2]. * **Morphology:** On Electron Microscopy, amyloid appears as **7.5–10 nm non-branching fibrils**. * **AL Amyloid:** Most common systemic type; associated with Plasma Cell Dyscrasias (Light chains). * **AA Amyloid:** Associated with chronic inflammation (e.g., RA, Osteomyelitis, TB). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 266. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 580-581. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, p. 580.

Question 227: All of the following are true for exudates, except?

A. It has a specific gravity of 1.018
B. It has a low fibrin content (Correct Answer)
C. It has more than 3% proteins
D. It is mucinous in consistency

Explanation: ### Explanation The distinction between **Exudate** and **Transudate** is a fundamental concept in General Pathology, primarily based on the mechanism of fluid formation and the integrity of the vascular endothelium. **Why Option B is the correct answer (The "Except" statement):** Exudates are characterized by **high fibrin content** [1]. Exudation occurs due to increased vascular permeability (usually during inflammation), which allows large molecular weight proteins like fibrinogen to escape the vessels into the interstitial space [1]. Once in the extravascular space, fibrinogen is converted to **fibrin**, often leading to the formation of a "fibrinous" clot [1]. In contrast, transudates have negligible fibrinogen and do not clot. **Analysis of Incorrect Options:** * **Option A (Specific Gravity > 1.018):** This is a classic feature of exudates. Because exudates are rich in proteins and cellular debris, they are denser than transudates (which typically have a specific gravity < 1.012). * **Option C (Proteins > 3%):** Exudates result from "leaky" capillaries, allowing significant protein leakage. They typically contain > 3 g/dL (3%) of protein, whereas transudates contain < 3 g/dL. * **Option D (Mucinous consistency):** Exudates can be mucinous, purulent, or serosanguinous depending on the underlying cause (e.g., mucin-secreting tumors or specific inflammatory states). --- ### High-Yield Clinical Pearls for NEET-PG | Feature | Transudate | Exudate | | :--- | :--- | :--- | | **Mechanism** | ↑ Hydrostatic pressure / ↓ Oncotic pressure | ↑ Vascular permeability (Inflammation) | | **Protein Content** | Low (< 3 g/dL) | **High (> 3 g/dL)** | | **LDH Levels** | Low (< 200 IU/L) | **High (> 200 IU/L)** | | **Cells** | Few (Mesothelial cells) | **Many (Inflammatory cells/Neutrophils)** | | **Light’s Criteria** | Pleural Fluid/Serum Protein Ratio < 0.5 | **Ratio > 0.5** | * **Mnemonic:** **E**xudate = **E**xtra protein, **E**xtra cells, and **E**nzymes (LDH). * **Clinical Example:** Congestive Heart Failure causes Transudate; Pneumonia or Malignancy causes Exudate [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 101-103. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 194-195.

Question 228: Ehlers-Danlos syndrome is due to a defect in which of the following?

A. Elastin
B. Collagen (Correct Answer)
C. Keratin
D. Laminin

Explanation: **Explanation:** **Ehlers-Danlos Syndrome (EDS)** is a clinically and genetically heterogeneous group of disorders characterized by a defect in the synthesis or structure of **fibrillar collagen** [1]. Collagen provides the necessary tensile strength to connective tissues; hence, its deficiency leads to the hallmark triad of **skin hyperextensibility, joint hypermobility, and tissue fragility** [1]. * **Why Collagen is Correct:** EDS results from mutations in genes encoding structural proteins (like Type I, III, or V collagen) or enzymes responsible for post-translational modifications (like lysyl hydroxylase) [1]. For example, the **Classical type** is associated with Type V collagen (COL5A1/A2), while the **Vascular type** involves Type III collagen (COL3A1). * **Why Incorrect Options are Wrong:** * **Elastin:** Defects in elastin or its scaffold protein, Fibrillin-1, lead to **Marfan Syndrome** or Cutis Laxa, not EDS. * **Keratin:** Mutations in keratin filaments primarily affect the epidermis, leading to disorders like **Epidermolysis Bullosa Simplex** or Ichthyosis. * **Laminin:** Laminins are major components of the basal lamina. Defects here are associated with certain types of **Junctional Epidermolysis Bullosa** and Muscular Dystrophy. **High-Yield Clinical Pearls for NEET-PG:** * **Vascular Type (Type IV):** Most serious form; involves Type III collagen. Risk of spontaneous rupture of large arteries or the colon [1]. * **Kyphoscoliotic Type:** Due to deficiency of **Lysyl Hydroxylase**; characterized by hypotonia and ocular fragility. * **Beighton Score:** Used clinically to assess the degree of joint hypermobility. * **Wound Healing:** Patients often exhibit "cigarette paper" or "papyraceous" scarring due to poor collagen cross-linking [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 154-156.

Question 229: Tumor marker CA 15-3 is associated with which type of cancer?

A. Ovarian cancer
B. Breast cancer (Correct Answer)
C. Prostate cancer
D. Renal cancer

Explanation: **Explanation:** **CA 15-3 (Cancer Antigen 15-3)** is a tumor marker primarily used in the clinical management of **Breast Cancer**. It is a product of the *MUC1* gene and is a high-molecular-weight glycoprotein found on the luminal surface of glandular epithelium. In malignant breast cells, this protein is overexpressed and shed into the bloodstream. While not used for screening due to low sensitivity in early stages, it is highly valuable for monitoring treatment response and detecting recurrence in patients with metastatic breast cancer. **Analysis of Incorrect Options:** * **Ovarian Cancer:** The primary tumor marker is **CA-125**. While CA 15-3 can occasionally be elevated in ovarian malignancy, it is not the diagnostic or monitoring standard. * **Prostate Cancer:** The gold standard marker is **PSA (Prostate-Specific Antigen)**. Acid phosphatase is another historical marker associated with this cancer. * **Renal Cancer:** There are no highly specific serum tumor markers for Renal Cell Carcinoma (RCC), though LDH or erythropoietin may sometimes be elevated. **High-Yield Clinical Pearls for NEET-PG:** * **CA 15-3 and CA 27-29:** Both are markers for breast cancer monitoring. * **CA 19-9:** Associated with Pancreatic and Cholangiocarcinoma. * **CA 125:** Associated with Serous Ovarian Cystadenocarcinoma. * **AFP (Alpha-fetoprotein):** Associated with Hepatocellular Carcinoma (HCC) and Yolk Sac Tumors. * **CEA (Carcinoembryonic Antigen):** Primarily used for Colorectal Cancer.

Question 230: In apoptosis, permeabilization of which membrane occurs?

A. Nuclear membrane
B. Cytoplasmic membrane
C. Lysosome
D. Mitochondrial membrane (Correct Answer)

Explanation: Apoptosis, or programmed cell death, is primarily regulated by the **mitochondrial (intrinsic) pathway**. The central event in this pathway is the **permeabilization of the outer mitochondrial membrane (MOMP)** [1]. This process is controlled by the BCL-2 family of proteins. Pro-apoptotic proteins like **BAX and BAK** form pores in the mitochondrial membrane, allowing the leakage of **Cytochrome c** into the cytosol [1]. Once in the cytosol, Cytochrome c binds to Apaf-1 to form the apoptosome, which activates Caspase-9, leading to the execution phase of cell death. **Analysis of Incorrect Options:** * **A. Nuclear membrane:** While the nucleus undergoes chromatin condensation (pyknosis) and fragmentation (karyorrhexis) during apoptosis, the nuclear membrane does not undergo primary permeabilization to initiate the process. * **B. Cytoplasmic membrane:** A hallmark of apoptosis is that the **plasma membrane remains intact** [3] (though its structure changes, such as the flipping of phosphatidylserine). This prevents the leakage of cellular contents and avoids an inflammatory response, distinguishing it from necrosis. * **C. Lysosome:** Lysosomal membrane permeabilization is typically associated with autophagic cell death or necrosis (via the release of hydrolytic enzymes), not the classic apoptotic cascade [3]. **High-Yield Facts for NEET-PG:** * **Anti-apoptotic proteins:** BCL-2, BCL-XL, and MCL-1 (they maintain membrane integrity) [2]. * **Pro-apoptotic proteins:** BAX and BAK (the "gatekeepers" of mitochondrial permeabilization) [2]. * **BH3-only proteins:** BIM, BID, and BAD (sensors of cellular stress that activate BAX/BAK). * **Marker of Apoptosis:** Presence of **Phosphatidylserine** on the outer leaflet of the plasma membrane (detected by Annexin V). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-67. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 60-61.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free